Literature DB >> 36183294

Spectrum of imaging findings in hyperplastic cholecystosis and potential mimics.

Dania G Malik1, Nirvikar Dahiya2, Meghan G Lubner3, P J Pickhardt3, Khaled M Elsayes4, Kathryn A Robinson5, Christine O Menias6.   

Abstract

Adenomyomatosis and cholesterolosis of the gallbladder, collectively termed hyperplastic cholecystosis, are commonly encountered incidental findings on imaging studies performed for a variety of indications including biliary colic or nonspecific abdominal pain. These pathologies are rarely the source of symptoms, generally considered benign and do not require further work-up. However, their imaging characteristics can overlap with more sinister conditions that should not be missed. In this review, the imaging findings of adenomyomatosis and cholesterolosis will be reviewed followed by other gallbladder pathologies that might mimic these conditions radiologically. Important differentiating factors will be discussed that can aid the radiologist in making a more confident imaging diagnosis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adenomyomatosis; Cholesterolosis; Gallbladder; Hyperplastic cholecystosis

Year:  2022        PMID: 36183294     DOI: 10.1007/s00261-022-03680-5

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  30 in total

Review 1.  Growth rate and malignant potential of small gallbladder polyps--systematic review of evidence.

Authors:  Rebecca Wiles; Mandar Varadpande; Sudha Muly; Jolanta Webb
Journal:  Surgeon       Date:  2014-02-04       Impact factor: 2.392

2.  Diverticular disease (adenomyomatosis) of the gallbladder: a radiological-pathological survey.

Authors:  I Williams; G Slavin; A Cox; P Simpson; G de Lacey
Journal:  Br J Radiol       Date:  1986-01       Impact factor: 3.039

3.  The hyperplastic cholecystoses: cholesterolosis and adenomyomatosis.

Authors:  R N Berk; J H van der Vegt; J E Lichtenstein
Journal:  Radiology       Date:  1983-03       Impact factor: 11.105

4.  Implications of gallbladder cholesterolosis and cholesterol polyps?

Authors:  Saif Dairi; Andrew Demeusy; Anne M Sill; Shirali T Patel; Gopal C Kowdley; Steven C Cunningham
Journal:  J Surg Res       Date:  2015-08-28       Impact factor: 2.192

5.  Longitudinal Ultrasound Assessment of Changes in Size and Number of Incidentally Detected Gallbladder Polyps.

Authors:  Andrew J Walsh; David B Bingham; Aya Kamaya
Journal:  AJR Am J Roentgenol       Date:  2021-09-22       Impact factor: 3.959

6.  Cholesterolosis. Incidence, correlation with serum cholesterol level and the role of laparoscopic cholecystectomy.

Authors:  Gamal A Khairy; Salman Y Guraya; Khalid R Murshid
Journal:  Saudi Med J       Date:  2004-09       Impact factor: 1.484

7.  Adenomyomatosis of the gallbladder.

Authors:  M M Meguid; F Aun; M L Bradford
Journal:  Am J Surg       Date:  1984-02       Impact factor: 2.565

Review 8.  Gallbladder polyps, cholesterolosis, adenomyomatosis, and acute acalculous cholecystitis.

Authors:  Charles C Owen; Lyman E Bilhartz
Journal:  Semin Gastrointest Dis       Date:  2003-10

Review 9.  Pathogenesis of gallbladder adenomyomatosis and its relationship with early-stage gallbladder carcinoma: an overview.

Authors:  Liwei Pang; Yan Zhang; Yuwen Wang; Jing Kong
Journal:  Braz J Med Biol Res       Date:  2018-05-21       Impact factor: 2.590

10.  Management and follow-up of gallbladder polyps : Joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery - European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE).

Authors:  Rebecca Wiles; Ruedi F Thoeni; Sorin Traian Barbu; Yogesh K Vashist; Søren Rafael Rafaelsen; Catherine Dewhurst; Marianna Arvanitakis; Max Lahaye; Marek Soltes; Julie Perinel; Stuart Ashley Roberts
Journal:  Eur Radiol       Date:  2017-02-09       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.